Effect of clot composition on thrombus resolution

描述（由申请人提供）：深静脉血栓形成（DVT）和随后的血栓后综合征（PTS）是每年影响许多美国人的严重健康问题。“开放静脉假说”假定快速清除静脉血栓对于降低PTS风险很重要。因此，了解血栓消退的过程对于改善DVT患者的临床管理至关重要。纤维蛋白是一种为血栓提供支持和稳定性的不溶性网状物，它与血栓形成的危险因素密切相关。我实验室最近的研究表明，高纤维蛋白原血症是急性血栓形成的原因。重要的是，高纤维蛋白原血症也增加了体内溶栓的抵抗力。这些发现支持了我的总体假设，即血栓成分（纤维蛋白含量）影响血栓消退的自然过程。在小鼠下腔静脉血栓消退的创新模型中的初步数据表明血栓纤维蛋白含量调节血栓稳定性和溶解。这些发现支持了两个调查目的。首先，使用体内和体外模型，我将通过测试两个问题来确定血栓成分（纤维蛋白含量）如何决定血栓消退的过程：1）纤维蛋白含量增加是否会延迟体内恢复通畅？2)纤维蛋白含量增加是否会增加凝块体积并减少血小板凝块收缩？其次，再次使用体内和体外模型，我将确定血栓成分如何影响血栓消退过程中白细胞功能。我将测试以下三个问题：1）纤维蛋白含量增加是否会改变白细胞向凝块的募集？2)纤维蛋白含量增加是否改变白细胞功能（细胞因子或纤维蛋白溶解介质的分泌）？3)纤维蛋白含量增加是否会改变白细胞通过血凝块的迁移？这些实验的结果将阐明有助于静脉血栓稳定性的机制。这些发现将通过提供关于血栓成分在血栓消退中的作用的信息来推进该领域，并确定加速血栓消退的靶点。

DESCRIPTION (provided by applicant): Deep vein thrombosis (DVT) and subsequent post-thrombotic syndrome (PTS) are serious health concerns affecting numerous Americans each year. The "open vein hypothesis" postulates that rapid removal of venous thrombi is important for reducing PTS risk. Understanding the course of thrombus resolution is therefore critical for improved clinical management of individuals with DVT. Fibrin-the insoluble meshwork that provides support and stability to a clot-lies at the nexus of risk factors contributing to thromboss. Recent work by my lab has shown that hyperfibrinogenemia is causative in acute thrombosis. Importantly, hyperfibrinogenemia also increased resistance to thrombolysis in vivo. These findings support my global hypothesis that thrombus composition (fibrin content) influences the natural course of thrombus resolution. Preliminary data in an innovative model of thrombus resolution in the murine inferior vena cava suggest thrombus fibrin content modulates thrombus stability and lysis. These findings support two aims of investigation. First, using in vivo and in vitro models, I will determine how thrombus composition (fibrin content) dictates the course of thrombus resolution by testing two questions: 1) Does increased fibrin content delay return to patency in vivo? 2) Does increased fibrin content increase clot volume and decrease platelet clot retraction? Second, again using in vivo and in vitro models, I will determine how thrombus composition influences leukocyte function during thrombus resolution. I will test the following three questions: 1) Does increased fibrin content alter leukocyte recruitment to the clot? 2) Does increased fibrin content alter leukocyte function (secretion of cytokines or fibrinolytic mediators? 3) Does increased fibrin content alter leukocyte migration through the clot? Results from these experiments will elucidate mechanisms contributing to venous thrombus stability. These findings will advance the field by providing information on the role of thrombus composition in thrombus resolution, and identify targets for accelerating thrombus resolution.